These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 3315608

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Anisoylated plasminogen streptokinase activator complex versus placebo. A preliminary multicentre study of safety and early mortality in acute myocardial infarction.
    Julian DG, Borthwick LS, Reid D, Jennings KP, Wainwright RJ, Rodger JC, Wood D, Phillips WS.
    Drugs; 1987; 33 Suppl 3():261-7. PubMed ID: 3315604
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tolerance and complications in a multicenter trial of intravenous APSAC and intracoronary streptokinase in acute myocardial infarction.
    Rothbard RL, Anderson JL, Fitzpatrick PG, Hakworthy RA, Sorensen SG, Marder VJ.
    Clin Cardiol; 1990 Mar; Suppl 5():V11-4; discussion V27-32. PubMed ID: 2182234
    [Abstract] [Full Text] [Related]

  • 8. Comparison of intravenous anisoylated plasminogen streptokinase activator complex and intracoronary streptokinase in acute myocardial infarction.
    Bonnier HJ, Visser RF, Klomps HC, Hoffmann HJ.
    Am J Cardiol; 1988 Jul 01; 62(1):25-30. PubMed ID: 3289357
    [Abstract] [Full Text] [Related]

  • 9. Intravenous anisoylated plasminogen streptokinase activator complex versus intravenous streptokinase in evolving myocardial infarction. Preliminary data from a randomised multicentre study.
    Brochier ML, Quilliet L, Kulbertus H, Materne P, Letac B, Cribier A, Monassier JP, Sacrez A, Favier JP.
    Drugs; 1987 Jul 01; 33 Suppl 3():140-5. PubMed ID: 3315581
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Haematological effects of anisoylated plasminogen streptokinase activator complex and streptokinase in patients with acute myocardial infarction. Interim report of the IRS II Study.
    Monassier JP, Hanssen M.
    Drugs; 1987 Jul 01; 33 Suppl 3():247-52. PubMed ID: 2445540
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Early clinical evaluation of the intravenous treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.
    Kasper W, Meinertz T, Wollschläger H, Bonzel T, Chen C, Hofmann T, Zeiher A, Drexler H, Just H.
    Drugs; 1987 Jul 01; 33 Suppl 3():112-6. PubMed ID: 3315575
    [Abstract] [Full Text] [Related]

  • 14. Development and evaluation of anisoylated plasminogen streptokinase activator complex (APSAC) as a second generation thrombolytic agent.
    Anderson JL.
    J Am Coll Cardiol; 1987 Nov 01; 10(5 Suppl B):22B-27B. PubMed ID: 3312369
    [Abstract] [Full Text] [Related]

  • 15. Summary of early clinical experience with anisoylated plasminogen streptokinase activator complex in the treatment of acute myocardial infarction.
    Jackson D.
    Drugs; 1987 Nov 01; 33 Suppl 3():104-11. PubMed ID: 3315574
    [Abstract] [Full Text] [Related]

  • 16. An interim report of a double-blind placebo-controlled recanalisation study of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Timmis AD, Griffin B, Crick JC, Flax JS, Sowton E.
    Drugs; 1987 Nov 01; 33 Suppl 3():146-50. PubMed ID: 3315582
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex in a district hospital. Efficacy data.
    Chamberlain DA.
    Drugs; 1987 Nov 01; 33 Suppl 3():221-2. PubMed ID: 3315596
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of intravenous anisoylated plasminogen streptokinase activator complex with intracoronary streptokinase in acute myocardial infarction.
    Bonnier JJ.
    Drugs; 1987 Nov 01; 33 Suppl 3():151-3. PubMed ID: 3315583
    [Abstract] [Full Text] [Related]

  • 20. Multicenter trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: effects on infarct size and left ventricular function.
    Bassand JP, Machecourt J, Cassagnes J, Anguenot T, Lusson R, Borel E, Peycelon P, Wolf E, Ducellier D.
    J Am Coll Cardiol; 1989 Apr 01; 13(5):988-97. PubMed ID: 2647817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.